EX-99.4 5 dex994.htm CONVERTIBLE NOTES REGISTRATION RIGHTS AGREEMENT Execution Copy VIROPHARMA INCORPORATED, as the Company and BUYERS, as defined herein CONVERTIBLE NOTES REGISTRATION RIGHTS AGREEMENT Dated as of October 18, 2004 CONVERTIBLE NOTES...Convertible Notes Registration Rights Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionTHIS CONVERTIBLE NOTES REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is entered into as of October 18, 2004, by and among VIROPHARMA INCORPORATED, a Delaware corporation (the “Company”), and the buyers listed on the Schedule of Buyers attached hereto as Exhibit A (each, a “Buyer” and, collectively, the “Buyers”).
CONSENT, WAIVER AND AMENDMENT TO CONVERTIBLE NOTES REGISTRATION RIGHTS AGREEMENTConvertible Notes Registration Rights Agreement • May 10th, 2005 • Viropharma Inc • Pharmaceutical preparations
Contract Type FiledMay 10th, 2005 Company IndustryTHIS CONSENT, WAIVER AND AMENDMENT (this “Amendment”) is made on this 6th day of May, 2005 by and among ViroPharma Incorporated, a Delaware corporation (the “Company”), and the investors who have delivered an executed counterpart signature page to this Amendment (collectively, the “Investors,” and each individually, an “Investor”). Capitalized terms used and not otherwise defined in this Amendment shall have the respective meanings ascribed to such terms in the Convertible Notes Registration Rights Agreement, dated October 18, 2004, among the Company and the other signatories thereto (the “Registration Rights Agreement”).
CONVERTIBLE NOTES REGISTRATION RIGHTS AGREEMENTConvertible Notes Registration Rights Agreement • February 5th, 2007 • Storm Cat Energy CORP • Crude petroleum & natural gas • New York
Contract Type FiledFebruary 5th, 2007 Company Industry JurisdictionTHIS CONVERTIBLE NOTES REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made and entered into this 19th day of January, 2007, by and among Storm Cat Energy Corporation, a company incorporated under the laws of the Province of British Columbia, Canada (the “Company”), and the undersigned Purchasers, in their capacity as both purchasers of Series A Notes (as defined below) and Series B Notes (as defined below) (each, a “Purchaser”, and collectively, the “Purchasers”).